This bill proposes to amend the Arizona Revised Statutes by adding a new chapter focused on prescription drugs, specifically addressing pricing and prohibiting price gouging for essential off-patent or generic drugs. The bill defines key terms such as "essential off-patent or generic drug," "price gouging," and "unconscionable increase," and establishes criteria for what constitutes price gouging. It prohibits manufacturers and wholesale distributors from engaging in price gouging and outlines the conditions under which price increases may be reported to the attorney general by the state medical assistance program.

Additionally, the bill grants the attorney general the authority to investigate price increases, requiring manufacturers to provide detailed cost breakdowns and justifications for price hikes. It allows for court orders to compel compliance, impose civil penalties, and restore funds to consumers affected by price gouging. The bill also ensures that any information shared with the attorney general remains confidential unless waived by the manufacturer or distributor. Overall, the proposed changes aim to enhance consumer protection and accountability in the pricing of essential prescription medications.